Cancer Research AACR Conference on Molecular Diagnostics  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 59, 5443-5448, November 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barr, F. G.
Right arrow Articles by Bennicelli, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barr, F. G.
Right arrow Articles by Bennicelli, J. L.
[Cancer Research 59, 5443-5448, November 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Predominant Expression of Alternative PAX3 and PAX7 Forms in Myogenic and Neural Tumor Cell Lines1

Frederic G. Barr2, Julie C. Fitzgerald, Jill P. Ginsberg3, Michelle L. Vanella, Richard J. Davis4 and Jeannette L. Bennicelli

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6082

PAX3 and PAX7 are closely related paired box family members expressed during early neural and myogenic development. Assay of PAX3 and PAX7 mRNA expression in embryonal rhabdomyosarcoma, neuroblastoma, Ewing’s sarcoma, and melanoma cell lines revealed tumor-specific expression patterns similar to the corresponding embryonic lineages. Although the mammalian PAX3 and PAX7 genes were reported to contain eight exons, we found that the predominant PAX3 and PAX7 transcripts in these tumor lines contain previously uncharacterized ninth exons. These splicing events alter the COOH-terminal coding regions of the encoded products but do not alter the transcriptional activity as assayed using a reporter gene with a model PAX3/PAX7 binding site. However, the findings of nearly identical COOH-terminal regions within the corresponding genes of the avian and fish genomes suggest conserved functional roles for these regions that require further investigation.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Q. Wang, S. Kumar, M. Slevin, and P. Kumar
Functional Analysis of Alternative Isoforms of the Transcription Factor PAX3 in Melanocytes In vitro.
Cancer Res., September 1, 2006; 66(17): 8574 - 8580.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S.-J. He, G. Stevens, A. W. Braithwaite, and M. R. Eccles
Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity
Mol. Cancer Ther., June 1, 2005; 4(6): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. D. Mackereth, S.-J. Kwak, A. Fritz, and B. B. Riley
Zebrafish pax8 is required for otic placode induction and plays a redundant role with Pax2 genes in the maintenance of the otic placode
Development, January 15, 2005; 132(2): 371 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. G. Harris, E. White, E. S. Phillips, and K. A. Lillycrop
The Expression of the Developmentally Regulated Proto-oncogene Pax-3 Is Modulated by N-Myc
J. Biol. Chem., September 13, 2002; 277(38): 34815 - 34825.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Pani, M. Horal, and M. R. Loeken
Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis
Genes & Dev., March 15, 2002; 16(6): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. A. Chansky, M. Hu, D. D. Hickstein, and L. Yang
Oncogenic TLS/ERG and EWS/Fli-1 Fusion Proteins Inhibit RNA Splicing Mediated by YB-1 Protein
Cancer Res., May 1, 2001; 61(9): 3586 - 3590.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Yang, H. A. Chansky, and D. D. Hickstein
EWS{middle dot}Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA Splicing
J. Biol. Chem., November 22, 2000; 275(48): 37612 - 37618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.